Drosophila model to clarify the pathological significance of OPA1 in autosomal dominant optic atrophy

被引:0
|
作者
Nitta, Yohei [1 ]
Osaka, Jiro [1 ,2 ]
Maki, Ryuto [2 ]
Hakeda-Suzuki, Satoko [2 ,3 ]
Suzuki, Emiko [4 ,5 ]
Ueki, Satoshi [6 ]
Suzuki, Takashi [2 ]
Sugie, Atsushi [1 ]
机构
[1] Niigata Univ, Brain Res Inst, Niigata, Japan
[2] Tokyo Inst Technol, Sch Life Sci & Technol, Yokohama, Japan
[3] Yokohama Natl Univ, Res Initiat & Promot Org, Yokohama, Japan
[4] Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Hachioji, Japan
[5] Natl Inst Genet, Dept Gene Funct & Phenom, Mishima, Japan
[6] Niigata Univ, Grad Sch Med & Dent Sci, Div Ophthalmol & Visual Sci, Niigata, Japan
来源
ELIFE | 2024年 / 12卷
基金
日本学术振兴会;
关键词
dominant optic atrophy; Drosophila; OPA1; axonal degeneration; DYNAMIN-RELATED PROTEIN; SCLEROSIS-LIKE DISORDER; MITOCHONDRIAL-DNA; MUTATIONS; DISEASE; REPLICATION; FUSION; GENES; MOUSE; PATHOGENICITY;
D O I
10.7554/eLife.87880
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Autosomal dominant optic atrophy (DOA) is a progressive form of blindness caused by degeneration of retinal ganglion cells and their axons, mainly caused by mutations in the OPA1 mitochondrial dynamin like GTPase (OPA1) gene. OPA1 encodes a dynamin-like GTPase present in the mitochondrial inner membrane. When associated with OPA1 mutations, DOA can present not only ocular symptoms but also multi-organ symptoms (DOA plus). DOA plus often results from point mutations in the GTPase domain, which are assumed to have dominant-negative effects. However, the presence of mutations in the GTPase domain does not always result in DOA plus. Therefore, an experimental system to distinguish between DOA and DOA plus is needed. In this study, we found that loss-of-function mutations of the dOPA1 gene in Drosophila can imitate the pathology of optic nerve degeneration observed in DOA. We successfully rescued this degeneration by expressing the human OPA1 (hOPA1) gene, indicating that hOPA1 is functionally interchangeable with dOPA1 in the fly system. However, mutations previously identified did not ameliorate the dOPA1 deficiency phenotype. By expressing both WT and DOA plus mutant hOPA1 forms in the optic nerve of dOPA1 mutants, we observed that DOA plus mutations suppressed the rescue, facilitating the distinction between loss-of-function and dominant-negative mutations in hOPA1. This fly model aids in distinguishing DOA from DOA plus and guides initial hOPA1 mutation treatment strategies.
引用
收藏
页数:25
相关论文
共 50 条
  • [21] Autosomal dominant optic atrophy: A novel treatment for OPA1 splice defects using U1 snRNA adaption
    Jueschke, Christoph
    Klopstock, Thomas
    Catarino, Claudia B.
    Owczarek-Lipska, Marta
    Wissinger, Bernd
    Neidhardt, John
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2021, 26 : 1186 - 1197
  • [22] Pattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutations
    P Yu-Wai-Man
    M Bailie
    A Atawan
    P F Chinnery
    P G Griffiths
    Eye, 2011, 25 : 596 - 602
  • [23] OPA1 analysis in an international series of probands with bilateral optic atrophy
    Liskova, Petra
    Tesarova, Marketa
    Dudakova, Lubica
    Svecova, Stepanka
    Kolarova, Hana
    Honzik, Tomas
    Seto, Sharon
    Votruba, Marcela
    ACTA OPHTHALMOLOGICA, 2017, 95 (04) : 363 - 369
  • [24] Not only dominant, not only optic atrophy: expanding the clinical spectrum associated with OPA1 mutations
    Nasca, Alessia
    Rizza, Teresa
    Doimo, Mara
    Legati, Andrea
    Ciolfi, Andrea
    Diodato, Daria
    Calderan, Cristina
    Carrara, Gianfranco
    Lamantea, Eleonora
    Aiello, Chiara
    Di Nottia, Michela
    Niceta, Marcello
    Lamperti, Costanza
    Ardissone, Anna
    Bianchi-Marzoli, Stefania
    Iarossi, Giancarlo
    Bertini, Enrico
    Moroni, Isabella
    Tartaglia, Marco
    Salviati, Leonardo
    Carrozzo, Rosalba
    Ghezzi, Daniele
    ORPHANET JOURNAL OF RARE DISEASES, 2017, 12 : 1 - 10
  • [25] Pattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutations
    Yu-Wai-Man, P.
    Bailie, M.
    Atawan, A.
    Chinnery, P. F.
    Griffiths, P. G.
    EYE, 2011, 25 (05) : 597 - 601
  • [26] First submicroscopic inversion of the OPA1 gene identified in dominant optic atrophy - a case report
    Weisschuh, Nicole
    Mazzola, Pascale
    Heinrich, Tilman
    Haack, Tobias
    Wissinger, Bernd
    Tonagel, Felix
    Kelbsch, Carina
    BMC MEDICAL GENETICS, 2020, 21 (01)
  • [27] A novel OPA1 mutation causing variable age of onset autosomal dominant optic atrophy plus in an Australian family
    Ahmad, K. E.
    Davis, R. L.
    Sue, C. M.
    JOURNAL OF NEUROLOGY, 2015, 262 (10) : 2323 - 2328
  • [28] Opa1 deficiency in a mouse model of dominant optic atrophy leads to retinal ganglion cell dendropathy
    Williams, Pete A.
    Morgan, James E.
    Votruba, Marcela
    BRAIN, 2010, 133 : 2942 - 2951
  • [29] Dysregulated mitophagy and mitochondrial organization in optic atrophy due to OPA1 mutations
    Liao, Chunyan
    Ashley, Neil
    Diot, Alan
    Morten, Karl
    Phadwal, Kanchan
    Williams, Andrew
    Fearnley, Ian
    Rosser, Lyndon
    Lowndes, Jo
    Fratter, Carl
    Ferguson, David J. P.
    Vay, Laura
    Quaghebeur, Gerardine
    Moroni, Isabella
    Bianchi, Stefania
    Lamperti, Costanza
    Downes, Susan M.
    Sitarz, Kamil S.
    Flannery, Padraig J.
    Carver, Janet
    Dombi, Eszter
    East, Daniel
    laura, Matilde
    Reilly, Mary M.
    Mortiboys, Heather
    Prevo, Remko
    Campanella, Michelangelo
    Daniels, Matthew J.
    Zeviani, Massimo
    Yu-Wai-Man, Patrick
    Simon, Anna Katharina
    Votruba, Marcela
    Poulton, Joanna
    NEUROLOGY, 2017, 88 (02) : 131 - 142
  • [30] Autosomal dominant optic atrophy plus due to the novel OPA1 variant c.1463G>C
    Finsterer, Josef
    Laccone, Franco
    METABOLIC BRAIN DISEASE, 2019, 34 (04) : 1023 - 1027